News

Dr. Melief will work to simplify and accelerate the acquisition of cord blood units for transplant and cell and gene therapies through expanded access for transplant centers, cord blood banks, and cell and gene therapy companies.

MINNEAPOLIS, MINN., May 24, 2023 – Results from a joint study between CIBMTR® (Center for International Blood and Marrow Transplant Research®)—a research collaboration between the National Marrow Donor Program® (NMDP)/Be The Match® and the Medical College of Wisconsin (MCW)—and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) defining COVID-19 vaccine response in allogeneic hematopoietic cell transplantation (HCT) were recently published in eClinicalMedicine.

MINNEAPOLIS, MINN., May 24, 2023 – Results from a joint study between CIBMTR^® (Center for International Blood and Marrow Transplant Research^®)—a research collaboration between the National Marrow Donor Program® (NMDP)/Be The Match® and the Medical College of Wisconsin (MCW)—and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) defining COVID-19 vaccine response in allogeneic hematopoietic cell transplantation (HCT) were recently published in eClinicalMedicine.

The observational study showed that use of cryopreserved hematopoietic stem cell grafts, did not impact patient overall survival compared to fresh grafts during the first year after transplant.

The Pre-MEASURE study was a multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in first remission.

Jeffery J. Auletta, MD, will Co-Chair the ASTCT Working Group with Stella M. Davies, MBBS, PhD, MRCP, Immediate Past President, ASTCT, Director, Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital.

The ONE Forum 2022 gives industry professionals practical strategies and best practices to break down barriers from diagnosis through treatment and recovery and expand access to treatment for more patients.

Virtual workshop on November 17 and 18 bridges the gap between critical stakeholders to pinpoint today’s challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.

National Marrow Donor Program®/Be The Match® Awards Amy Strelzer Manasevit Research Program Grant to Dan Peltier, MD, PhD. The grant provides $400,000 over five years of research to improve post-transplant health outcomes.

Approach for mismatched, unrelated bone marrow donors could expand transplant options for racially/ethnically diverse patients

The TRANSPLANT Act would reauthorize the C.W. Bill Young Cell Transplantation Program, which provides lifesaving bone marrow and umbilical cord blood transplants to patients in need

Assessing HLA-mismatched unrelated donor hematopoietic cell transplantation with post-transplantation cyclophosphamide

BMT CTN research presented today at the 62nd ASH Annual Meeting & Exposition   MINNEAPOLIS, MINN.—DEC. 5, 2020— Initial results from a recent study indicate that for patients between the ages of 50 and 75, overall survival nearly doubled when patients with myelodysplastic syndrome (MDS) re

Service helps increase donor availability and add reliability to a patient’s transplant timeline

Program offers more convenience for blood stem cell donors, more reliability for patients and physicians

The National Marrow Donor Program ® (NMDP)/Be The Match ® today announced the appointment of Amy Ronneberg as Chief Executive Officer (CEO)—the first female CEO for the organization.

MN Medicaid patients now have access to potentially life-saving clinical trials.